New retinopathy guidelines, and issues injecting in public |
|
|
|
This week, tackling complications has been the focus of diabetes news. One of week’s biggest stories so far was the news that the UK National Screening Committee (NSC) has revised its recommendations regarding screening for diabetic retinopathy.
The NSC is now suggesting that people with type 1 diabetes at low risk of sight loss should be screened for diabetic retinopathy every two years, rather than annually. The guidelines are unchanged for people with high risk of sight loss.
Elsewhere, the National Human Genome Research Institute (NHGRI) has launched a centre where the genomic factors behind type 1 diabetes will be explored through genome sequencing. The researchers will also be investigating diseases such as heart disease and stroke, which people with type 1 are more likely to develop than those without diabetes.
One of the biggest challenges people with type 1 diabetes can face is injecting in public. On the Diabetes Forum, alicerebekah asked “I recently have found myself having to inject in public. Once I went to the bathroom but didn't like doing it in there. A second time I did it out where people could see. I obviously did it as discreetly as possible but some people did see and I got a lot of glares.”
Injecting in public can divide opinion; some may be comfortable doing so, but others may prefer to have privacy. Injecting in public can draw unwanted attention, but providing you are safe, you should feel free to do so. Otherwise, do whatever makes you feel most comfortable.
Also, trending this week is the blog on the bizarre relationships between animals and diabetes. Some of the findings could have implications for human research.
|
|